These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4395069)

  • 1. Effects of chronic morphine administration on the catecholamine depletion induced by reserpine.
    Gunne LM; Jonsson J; Fuxe K
    J Pharm Pharmacol; 1970 Jul; 22(7):550-2. PubMed ID: 4395069
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of reserpine in morphine-tolerant rats: absence of an antagonism of catecholamine depletion.
    Blosser JC; Catravas GN
    J Pharmacol Exp Ther; 1974 Nov; 191(2):284-9. PubMed ID: 4422904
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective depleting effect of syrosingopine on brain catecholamine levels with relation to morphine analgesia in the rat.
    Furukawa T; Sano T; Kohno Y; Koga M; Nagasaki N
    Pharmacol Biochem Behav; 1976 Apr; 4(4):419-25. PubMed ID: 6976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of losulazine and reserpine on central aminergic neurons.
    Pan JT; Hooth MJ; Lookingland KJ; Moore KE; Marks TA
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):26-33. PubMed ID: 8236258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 6-hydroxydopamine on catecholamine concentrations and behaviour in the morphine-tolerant rat.
    Nakamura K; Kuntzman R; Maggio A; Conney AH
    J Pharm Pharmacol; 1972 Jun; 24(6):484-7. PubMed ID: 4403831
    [No Abstract]   [Full Text] [Related]  

  • 6. Mouse brain catecholamines, 5-hydroxytryptamine and the antinociceptive activity of pethidine.
    Pleuvry BJ
    Eur J Pharmacol; 1975 Dec; 34(2):351-61. PubMed ID: 1234554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Central depletion of transmitters by reserpine and motor behavior in the rat (author's transl)].
    Funk KF; Schmidt J; Westermann KH
    Acta Biol Med Ger; 1980; 39(8-9):923-7. PubMed ID: 7282222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of calcium in the reserpine-induced cerebral monoamines depletion.
    Radouco-Thomas S; Tessier L; Lajeunesse N; Garcin F
    Int Z Klin Pharmakol Ther Toxikol; 1971 Aug; 5(1):5-11. PubMed ID: 5570063
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of morphine administration on catecholamine levels in rat brain; specific reduction of epinephrine concentration in hypothalamus.
    Ota M; Mefford IN; Naoi M; Linnoila M
    Neurosci Lett; 1991 Jan; 121(1-2):129-32. PubMed ID: 2020369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the relationship between morphine analgesia and the brain catecholamines in mice.
    Paalzow L; Paalzow G
    Acta Pharmacol Toxicol (Copenh); 1971; 30(1):104-14. PubMed ID: 5171344
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of catecholamine synthesis and conditioned avoidance acquisition.
    Ahlenius S
    Pharmacol Biochem Behav; 1973; 1(3):347-50. PubMed ID: 4775861
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neurochemical basis of the pathogenesis of different types of addiction].
    Anokhina IP; Kogan BM; Khristoliubova NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(6):751-8. PubMed ID: 474021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebral catecholamine depletion in mice withdrawn from repeated morphine treatment and development of tolerance to the enhancing effect of morphine on noradrenaline depletion.
    Etemadzadeh E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):749-55. PubMed ID: 8355206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of morphine intoxication on brain catecholamine neurons.
    Gunne LM; Jonsson J; Fuxe K
    Eur J Pharmacol; 1969 Mar; 5(4):338-42. PubMed ID: 4306742
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of 6-hydroxydopamine on the antinociceptive action of morphine.
    Slater P; Blundell C
    Eur J Pharmacol; 1978 Apr; 48(3):237-47. PubMed ID: 639852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of catecholamine turnover rate in brain regions of rats exposed prenatally to morphine.
    Vathy I; Rimanoczy A; Eaton RC; Katay L
    Brain Res; 1994 Oct; 662(1-2):209-15. PubMed ID: 7859073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1971 May; 42(1):88-99. PubMed ID: 5580702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine effects on the levels and turnover of catecholamines in rat brain.
    Johnson JC; Ratner M; Gold CJ; Clouet DH
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):41-53. PubMed ID: 4438827
    [No Abstract]   [Full Text] [Related]  

  • 20. Catecholamine levels in the whole brain and the probability of memory formation are not related.
    Palfai T; Brown OM; Walsh TJ
    Pharmacol Biochem Behav; 1978 Jun; 8(6):717-21. PubMed ID: 308663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.